falseQ20001852736--12-31Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”).P1Y23000000230000002300000023000000This number excludes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters. On November 3, 2021, the underwriters exercised the full over-allotment. 0001852736 2022-06-30 0001852736 2021-12-31 0001852736 2021-04-01 2021-06-30 0001852736 2022-01-01 2022-06-30 0001852736 2021-03-05 2021-06-30 0001852736 2022-04-01 2022-06-30 0001852736 2021-03-05 2021-03-31 0001852736 2021-11-03 2021-11-03 0001852736 2022-01-01 2022-03-31 0001852736 2021-10-18 2021-10-18 0001852736 2022-03-31 0001852736 2021-03-04 0001852736 2021-06-30 0001852736 2021-03-31 0001852736 us-gaap:CommonClassAMember 2022-06-30 0001852736 us-gaap:CommonClassBMember 2022-06-30 0001852736 srt:MinimumMember 2022-06-30 0001852736 tris:SharePriceEqualsOrExceedsTwelveUsdMember us-gaap:CommonClassAMember 2022-06-30 0001852736 tris:WorkingCapitalLoanMember 2022-06-30 0001852736 tris:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2022-06-30 0001852736 tris:UnderwritingAgreementMember 2022-06-30 0001852736 us-gaap:PrivatePlacementMember tris:ForwardPurchaseInvestorsEachMember tris:ForwardPurchaseAgreementsMember us-gaap:CommonClassAMember 2022-06-30 0001852736 us-gaap:CommonClassBMember tris:SponsorMember 2022-06-30 0001852736 tris:ProspectiveConversionFromClassBToClassACommonStockMember 2022-06-30 0001852736 tris:PublicWarrantsMember 2022-06-30 0001852736 tris:PrivatePlacementWarrantsMember 2022-06-30 0001852736 tris:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember tris:PublicWarrantsMember 2022-06-30 0001852736 tris:PublicWarrantsMember tris:ProspectiveWarrantRedemptionMember 2022-06-30 0001852736 tris:PrivatePlacementWarrantMember 2022-06-30 0001852736 us-gaap:OverAllotmentOptionMember tris:PrivatePlacementWarrantMember 2022-06-30 0001852736 tris:WarrantsToSubscribeForClassACommonStockMember 2022-06-30 0001852736 tris:ElevenAnchorInvestorsMember 2022-06-30 0001852736 tris:FounderSharesMember 2022-06-30 0001852736 us-gaap:AccruedLiabilitiesMember tris:SponsorMember tris:ServiceAndAdministrativeFeesMember 2022-06-30 0001852736 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001852736 tris:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001852736 us-gaap:FairValueInputsLevel2Member tris:PublicWarrantMember 2022-06-30 0001852736 tris:PublicWarrantMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001852736 tris:PublicWarrantMember 2022-06-30 0001852736 us-gaap:FairValueInputsLevel1Member tris:PrivatePlacementWarrantsMember 2022-06-30 0001852736 us-gaap:FairValueInputsLevel2Member tris:PrivatePlacementWarrantsMember 2022-06-30 0001852736 us-gaap:FairValueInputsLevel3Member tris:PrivatePlacementWarrantsMember 2022-06-30 0001852736 us-gaap:FairValueInputsLevel1Member 2022-06-30 0001852736 us-gaap:FairValueInputsLevel2Member 2022-06-30 0001852736 us-gaap:MeasurementInputSharePriceMember 2022-06-30 0001852736 us-gaap:MeasurementInputExercisePriceMember 2022-06-30 0001852736 us-gaap:MeasurementInputExpectedDividendRateMember 2022-06-30 0001852736 us-gaap:MeasurementInputExpectedTermMember 2022-06-30 0001852736 us-gaap:MeasurementInputPriceVolatilityMember 2022-06-30 0001852736 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-06-30 0001852736 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2022-06-30 0001852736 us-gaap:CommonClassAMember 2021-12-31 0001852736 us-gaap:CommonClassBMember 2021-12-31 0001852736 tris:ServiceAndAdministrativeFeesMember tris:SponsorMember us-gaap:AccruedLiabilitiesMember 2021-12-31 0001852736 tris:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001852736 tris:PublicWarrantMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001852736 tris:PublicWarrantMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852736 tris:PublicWarrantMember 2021-12-31 0001852736 tris:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001852736 us-gaap:FairValueInputsLevel2Member tris:PrivatePlacementWarrantsMember 2021-12-31 0001852736 tris:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852736 tris:PrivatePlacementWarrantsMember 2021-12-31 0001852736 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001852736 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001852736 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001852736 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001852736 us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001852736 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001852736 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001852736 us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001852736 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001852736 srt:MaximumMember 2022-01-01 2022-06-30 0001852736 srt:MinimumMember 2022-01-01 2022-06-30 0001852736 us-gaap:CapitalUnitsMember 2022-01-01 2022-06-30 0001852736 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001852736 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001852736 tris:ForwardPurchaseAgreementsMember tris:OneOfTheForwardPurchaseInvestorsMember 2022-01-01 2022-06-30 0001852736 tris:PublicWarrantsMember 2022-01-01 2022-06-30 0001852736 tris:ProspectiveWarrantRedemptionMember tris:PublicWarrantsMember 2022-01-01 2022-06-30 0001852736 tris:PublicWarrantsMember tris:EventTriggeringAdjustmentToExercisePriceOfWarrantsMember 2022-01-01 2022-06-30 0001852736 tris:PrivatePlacementWarrantsMember 2022-01-01 2022-06-30 0001852736 tris:PrivatePlacementWarrantMember 2022-01-01 2022-06-30 0001852736 tris:PrivatePlacementWarrantMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-06-30 0001852736 us-gaap:IPOMember 2022-01-01 2022-06-30 0001852736 us-gaap:CommonClassBMember tris:NonRedeemableCommonStockMember 2022-01-01 2022-06-30 0001852736 us-gaap:CommonClassAMember tris:CommonStockSharesSubjectToPossibleRedemptionMember 2022-01-01 2022-06-30 0001852736 tris:PrivatePlacementWarrantMember us-gaap:WarrantMember 2022-01-01 2022-06-30 0001852736 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001852736 tris:FounderSharesMember 2022-01-01 2022-06-30 0001852736 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-01-01 2022-06-30 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-01-01 2021-12-31 0001852736 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001852736 us-gaap:CommonClassBMember tris:NonRedeemableCommonStockMember 2022-04-01 2022-06-30 0001852736 us-gaap:CommonClassAMember tris:CommonStockSharesSubjectToPossibleRedemptionMember 2022-04-01 2022-06-30 0001852736 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001852736 us-gaap:CommonClassBMember tris:NonRedeemableCommonStockMember 2021-04-01 2021-06-30 0001852736 tris:CommonStockSharesSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001852736 tris:CommonStockSharesSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-03-05 2021-06-30 0001852736 us-gaap:CommonClassBMember tris:NonRedeemableCommonStockMember 2021-03-05 2021-06-30 0001852736 us-gaap:OverAllotmentOptionMember 2021-10-18 0001852736 tris:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember tris:SponsorMember 2021-10-18 0001852736 us-gaap:CommonClassAMember tris:ProposedPublicOfferingMember 2021-10-18 0001852736 us-gaap:CommonClassAMember tris:ProposedPublicOfferingMember tris:PublicWarrantMember 2021-10-18 0001852736 tris:SponsorMember tris:FounderSharesMember tris:OneOfTheAnchorInvestorsMember 2021-10-18 0001852736 tris:SponsorMember tris:FounderSharesMember tris:OtherAnchorInvestorsMember 2021-10-18 0001852736 tris:UnderwritersMember tris:ProposedPublicOfferingMember 2021-10-18 2021-10-18 0001852736 tris:ProposedPublicOfferingMember us-gaap:CommonClassAMember 2021-10-18 2021-10-18 0001852736 tris:OneOfTheAnchorInvestorsMember tris:SponsorMember tris:FounderSharesMember 2021-10-18 2021-10-18 0001852736 tris:OtherAnchorInvestorsMember tris:SponsorMember tris:FounderSharesMember 2021-10-18 2021-10-18 0001852736 tris:PrivatePlacementWarrantMember 2021-11-03 2021-11-03 0001852736 tris:SponsorMember tris:PrivateplacementandoverallotmentoptionMember tris:PrivatePlacementWarrantMember 2021-11-03 2021-11-03 0001852736 us-gaap:OverAllotmentOptionMember 2021-11-03 2021-11-03 0001852736 tris:UnderwritersMember us-gaap:OverAllotmentOptionMember 2021-10-13 0001852736 tris:UnderwritersMember us-gaap:OverAllotmentOptionMember 2021-11-03 0001852736 tris:ProposedPublicOfferingMember tris:AnchorInvestorsMember us-gaap:CommonClassAMember 2021-11-03 0001852736 us-gaap:CommonClassBMember tris:SponsorMember 2021-03-15 0001852736 us-gaap:CommonClassBMember tris:SponsorMember 2021-08-01 2021-08-31 0001852736 tris:BeforeForfeitureMember tris:SponsorMember us-gaap:CommonClassBMember 2021-08-31 0001852736 tris:SponsorMember us-gaap:CommonClassBMember 2021-08-31 0001852736 tris:SponsorMember tris:TheNoteMember 2021-03-09 0001852736 tris:SponsorMember tris:AmendedNoteMember 2021-05-31 0001852736 tris:SponsorMember tris:ServiceAndAdministrativeFeesMember 2021-03-05 2021-12-31 0001852736 tris:FounderSharesMember 2021-03-01 2021-03-31 0001852736 srt:ChiefFinancialOfficerMember tris:FounderSharesMember 2021-03-01 2021-03-31 0001852736 tris:FounderSharesMember 2021-11-01 2021-11-30 0001852736 tris:FounderSharesMember srt:DirectorMember 2021-11-01 2021-11-30 0001852736 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-01-01 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-03-31 0001852736 tris:AsRestatedMember 2022-01-01 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001852736 us-gaap:CommonClassAMember tris:AsRestatedMember 2022-01-01 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001852736 tris:AsRestatedMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852736 tris:AsRestatedMember us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852736 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-05 2021-03-31 0001852736 us-gaap:AdditionalPaidInCapitalMember 2021-03-05 2021-03-31 0001852736 us-gaap:RetainedEarningsMember 2021-03-05 2021-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember 2022-03-31 0001852736 tris:AsRestatedMember 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassAMember 2022-03-31 0001852736 us-gaap:CommonClassAMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2022-03-31 0001852736 tris:AsRestatedMember us-gaap:CommonClassAMember 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassBMember 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:CommonClassBMember 2022-03-31 0001852736 tris:AsRestatedMember us-gaap:CommonClassBMember 2022-03-31 0001852736 us-gaap:CommonClassAMember 2022-03-31 0001852736 us-gaap:CommonClassBMember 2022-03-31 0001852736 us-gaap:CommonClassBMember 2022-08-15 0001852736 us-gaap:CommonClassAMember 2022-08-15 0001852736 us-gaap:WarrantMember tris:PrivatePlacementWarrantMember 2021-12-31 0001852736 tris:PublicWarrantsMember us-gaap:WarrantMember 2021-12-31 0001852736 us-gaap:WarrantMember 2021-12-31 0001852736 us-gaap:WarrantMember tris:PrivatePlacementWarrantMember 2022-06-30 0001852736 tris:PublicWarrantsMember us-gaap:WarrantMember 2022-06-30 0001852736 us-gaap:WarrantMember 2022-06-30 0001852736 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001852736 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001852736 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001852736 us-gaap:RetainedEarningsMember 2022-06-30 0001852736 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-06-30 0001852736 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-06-30 0001852736 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001852736 us-gaap:RetainedEarningsMember 2021-06-30 0001852736 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001852736 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852736 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852736 us-gaap:RetainedEarningsMember 2021-12-31 0001852736 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001852736 us-gaap:RetainedEarningsMember 2022-03-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-12-31 0001852736 us-gaap:RetainedEarningsMember srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-12-31 0001852736 tris:AsRestatedMember us-gaap:RetainedEarningsMember 2021-12-31 0001852736 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-12-31 0001852736 tris:AsRestatedMember 2021-12-31 0001852736 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2022-03-31 0001852736 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:RetainedEarningsMember 2022-03-31 0001852736 tris:AsRestatedMember us-gaap:RetainedEarningsMember 2022-03-31 0001852736 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-03-04 0001852736 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-04 0001852736 us-gaap:AdditionalPaidInCapitalMember 2021-03-04 0001852736 us-gaap:RetainedEarningsMember 2021-03-04 0001852736 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001852736 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001852736 us-gaap:RetainedEarningsMember 2021-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to _________
 
 
TRISTAR ACQUISITION I CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
  
001-40905
  
98-1587643
(State or other jurisdiction of
incorporation or organization)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
   
2870 Peachtree Road, NW Suite 509
Atlanta,
Georgia
  
30305
(Address Of Principal Executive Offices)
  
(Zip Code)
(412)
327-9294
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class:
  
Trading
Symbol:
  
Name of Each Exchange
on Which Registered:
Units, each consisting of one Class A ordinary share, $0.0001 par value, and
one-half
of one redeemable warrant
  
TRIS.U
  
The New York Stock Exchange
Class A ordinary shares included as part of the units
  
TRIS
  
The New York Stock Exchange
Redeemable warrants included as part of the units
  
TRIS.WS
  
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   ☒     No   ☐
Indicate by check mark whether
the
registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes   ☒     No   ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).     Yes  ☒    No  ☐
As of August 
15
, 2022, 23,000,000 Class A ordinary shares, par value $0.0001 per share, and 5,750,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, r
espectively.
 
 
 
TRISTAR ACQUISITION I CORP.
Form
10-Q
For the six months ended June 30, 2022
Table of Contents
 
  
 
1
 
Item 1.
 
  
 
1
 
 
  
 
1
 
 
  
 
2
 
 
  
 
3
 
 
  
 
4
 
 
  
 
5
 
Item 2.
 
  
 
21
 
Item 3.
 
  
 
25
 
Item 4.
 
  
 
26
 
  
 
28
 
Item 1.
 
  
 
28
 
Item 1A.
 
  
 
28
 
Item 2.
 
  
 
29
 
Item 3.
 
  
 
29
 
Item 4.
 
  
 
29
 
Item 5.
 
  
 
29
 
Item 6.
 
  
 
29
 
  
 
31
 
 
 
i
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements (Unaudited)
TRISTAR ACQUISITION I CORP.
CONDENSED BALANCE SHEETS
For the six months ended June 30, 2022 and year ended December 31, 2021
 
 
  
June 30,

2022
 
 
December 31,
2021
 
 
  
(Unaudited)
 
 
 
 
ASSETS
  
 
CURRENT ASSETS:
  
 
Cash
   
$

 761,186     $ 1,231,992  
Prepaid expenses
      355,379       307,045  
    
 
 
    
 
 
  
Total current assets
      1,116,565       1,539,037  
    
 
 
    
 
 
  
Prepaid expenses, net of current portion
      82,976       259,888  
Investments
 held in trust account
      232,461,777       232,302,491  
    
 
 
    
 
 
  
TOTAL ASSETS
   
$

  233,661,318     $  234,101,416  
    
 
 
    
 
 
  
LIABILITIES AND SHAREHOLDERS’ DEFICIT
 
        
CURRENT LIABILITIES:
                 
Accounts payable
   
$
 24,523     $ 131,541  
Accrued expenses
      84,516       127,875  
    
 
 
    
 
 
  
Total current liabilities
      109,039       259,416  
    
 
 
    
 
 
  
LONGTERM LIABILITIES:
                 
Derivative warrant liabilities
      2,261,400       9,684,400  
Deferred underwriting fee payable
      10,350,000       10,350,000  
    
 
 
    
 
 
  
Total long term liabilities
      12,611,400       20,034,400  
    
 
 
    
 
 
  
Total liabilities
      12,720,439       20,293,816  
    
 
 
    
 
 
  
Commitments and
contingencies (Note 6)
                 
Class A ordinary shares subject to possible redemption, 23,000,000 at redemption value
      232,459,286       232,300,000  
Shareholders’ deficit:
                 
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
      —         —    
Class A ordinary shares, $0.0001 par value; 90,000,000 shares authorized; no shares issued and outstanding
      —         —    
Class B ordinary shares, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding
      575       575  
Additional
paid-in
capital
      —         —    
Accumulated deficit
      (11,518,982 )
 
     (18,492,975 ) 
    
 
 
    
 
 
  
Total
shareholders’ deficit
      (11,518,407 )     (18,492,400 ) 
    
 
 
    
 
 
  
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT
   
$

 233,661,318     $ 234,101,416  
    
 
 
    
 
 
  
 
See accompanying notes to unaudited condensed financial statements.
1
TRISTAR ACQUISITION I CORP.
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
For the three and six months ended June 30, 2022 and for the three months ended June 30, 2021 and for the period from March 5, 2021 (inception) through June 30, 2021
 
 
  
Three Months
Ended June 30,
2022
 
  
Three Months
Ended June 30,
2021
 
 
Six Months
Ended June 30,
2022
 
 
For the period
from March 5,
2021 (inception)
through June 30,
2021
 
General and administrative expenses
    $ (191,634)     $ (109,762 )    $ (449,371 )    $  (121,066 ) 
    
 
 
    
 
 
    
 
 
    
 
 
  
Loss from operations
      (191,634)       (109,762 )      (449,371 )    $ (121,066 ) 
Other income
                                 
Interest income
      153,796       —         159,650       —    
Change in fair value of warrant liability
      5,276,600       —         7,423,000       —    
    
 
 
    
 
 
    
 
 
    
 
 
  
Total other income
      5,430,396       —         7,582,650       —    
    
 
 
    
 
 
    
 
 
    
 
 
  
Net income (loss)
    $ 5,238,762     $
 (109,762 )    $ 7,133,279     $  (121,066 ) 
    
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to redemption
      23,000,000       —         23,000,000       —    
    
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income (loss) per share, Class A ordinary shares subject to redemption
    $ 0.18     $ —       $ 0.25     $ —    
    
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class B ordinary shares
(1)
      5,750,000       5,000,000       5,750,000       5,000,000  
    
 
 
    
 
 
    
 
 
    
 
 
  
Basic and diluted net income (loss) per share, Class B ordinary shares
    $ 0.18     $ (0.02
)
 		   $ 0.25     $ (0.02 )
    
 
 
    
 
 
    
 
 
    
 
 
  
 
(1)
This number excludes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters. On November 3, 2021, the underwriters exercised the full over-allotment.
 
See accompanying notes to unaudited condensed financial statements.
2
TRISTAR ACQUISITION I CORP.
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT (UNAUDITED)
For the six months ended June 30, 2022 and the period from March 5, 2021 (inception) through June 30, 2021
 
                  
                  
                  
                  
                  
                  
                  
 
  
SIX MONTHS ENDED JUNE 30, 2022
 
 
  
Ordinary Shares
 
  
Additional
Paid-in

Capital
 
  
 
 
 
Total
Shareholders’
Deficit
 
 
  
Class A
 
  
Class B
 
  
Accumulated
Deficit
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
Balance - January 1, 2022
   
 
—  
 
   
$
 —  
 
   
 
5,750,000
 
   
$
 575
 
   
$
 —  
 
   
$
 (18,492,975
) 
  
$
 (18,492,400
) 
Net income
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
1,894,517
 
 
 
1,894,517
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
Balance - March 31, 2022
  
 
—  
 
  
 
—  
 
  
 
5,750,000
 
  
 
575
 
  
 
—  
 
  
 
(16,598,458
) 
 
 
(16,597,883
) 
Remeasurement of Class A ordinary shares to
redemption amount as of June 30, 2022
   
 
—
  
 
   
 
—
  
 
   
 
— 
 
 
   
 
—
  
 
   
 
— 
 
 
   
 
 (159,286)
 
  
 
(159,286)
 
Net income
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
5,238,762
 
  
 
5,238,762
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - June 30, 2022
   
 
—  
 
   
$
—  
 
   
 
5,750,000
 
   
$
575
 
   
$
—  
 
   
$
 (11,518,982
 )  
$
 (11,518,407
 )
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
 
                     
                     
                     
                     
                     
                     
                     
 
  
FOR THE PERIOD FROM MARCH 5, 2021 (INCEPTION) THROUGH JUNE 30, 2021
 
 
  
Ordinary Shares
 
  
Additional
Paid-in

Capital
 
  
 
 
 
Total
Shareholders’
Deficit
 
 
  
Class A
 
  
Class B
 
  
Accumulated
Deficit
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
Balance - March 5, 2021 (inception)
   
 
—  
 
   
$
 —  
     
 
—  
 
   
$
—  
 
   
$
—  
 
   
$
—  
 
  
$
—  
 
Issuance of Class B ordinary
shares(1)
   
 
—  
 
   
 
—  
 
   
 
5,000,000
 
   
 
500
 
   
 
24,500
 
   
 
—  
 
  
 
25,000
 
Net loss
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
(11,304
) 
 
 
(11,304
) 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
Balance - March 31, 2021
  
 
—  
 
  
 
—  
 
  
 
5,000,000
 
  
 
500
 
  
 
24,500
 
  
 
(11,304
) 
 
 
13,696
 
Net loss
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
(109,762
) 
  
 
(109,762
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance - June 30, 2021
   
 
—  
 
   
$
—  
 
   
 
5,000,000
 
   
$
 500
 
   
$
 24,500
 
   
$
 (121,066
) 
  
$
 (96,066
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
 
(1)
This number excludes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters. On November 3, 2021, the underwriters exercised the full over-allotment.
 
See accompanying notes to unaudited condensed financial statements.
3
TRISTAR ACQUISITION I CORP.
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the six months ended June 30, 2022 and for the period from March 5, 2021 (inception) through June 30, 2021
 
 
  
June 30, 2022
 
 
For the
period from
March 5,
2021
(inception)
through
June 30,
2021
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                 
Net income (loss)
    $ 7,133,279     $  (121,066 ) 
Adjustments to reconcile net income (loss) to net cash used in operating activities:
                 
Change in derivative warrant liabilities
      (7,423,000 )      —    
Interest income earned on investment held in Trust Account
      (159,286 )      —    
Changes in operating assets and liabilities:
                 
Prepaid expenses
      128,578       (40,150 ) 
Deferred offering costs
      —         (516,908 ) 
Accounts payable
      (107,018 )      —    
Accrued expenses
      (43,359 )     410,316  
    
 
 
    
 
 
  
Net cash used in operating activities
      (470,806 )      (267,808 ) 
    
 
 
    
 
 
  
CASH FLOWS FROM FINANCING ACTIVITIES:
                 
Proceeds from promissory note—related party
      —         246,149  
Proceeds from issuance of Class B ordinary shares to Sponsor
      —         25,000  
    
 
 
    
 
 
  
Net cash provided by financing activities
      —         271,149  
    
 
 
    
 
 
  
NET (DECREASE) INCREASE IN CASH
      (470,806 )      3,341  
CASH BEGINNING OF PERIOD
      1,231,992       —    
    
 
 
    
 
 
  
CASH END OF PERIOD
    $ 761,186     $ 3,341  
    
 
 
    
 
 
  
SUPPLEMENTAL DISCLOSURE OF
NON-CASH
ACTIVITIES:
                 
Deferred offering costs included in accounts payable and accrued expenses
    $ —       $ 431,000  
 
 
 
 
 
 
 
 
 
Remeasurement of Class A ordinary shares to redemption amount as of June 30, 2022
    $ 159,286     $ —    
    
 
 
    
 
 
  
 
See accompanying notes to unaudited condensed financial statements.
4
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note 1—Description of Organization and Business Operations and Liquidity
Tristar Acquisition I Corp. (the “Company”) is a blank check company incorporated in the Cayman Islands on March 5, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (a “Business Combination”).
The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2022 and December 31, 2021, the Company had not yet commenced any operations. All activity through June 30, 2022 relates to the Company’s formation and the initial public offering (“IPO”) described below and since completion of the IPO, searching for a target with which to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31
st
 as its fiscal year end.
The Company’s sponsor is Tristar Holdings I LLC, a Delaware limited liability company (the “Sponsor”)
Initial Public Offering
The registration statement for the Company’s Initial Public Offering was declared effective on October 13, 2021. On October 18, 2021, the Company consummated the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating total gross proceeds of $200,000,000, which is described in Note 3. On November 3, 2021, the underwriters exercised the over-allotment option (“over-allotment option”) and purchased an additional 3,000,000 Units, generating gross proceeds of $30 million, which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering and the over-allotment option, the Company consummated the sale of 7,345,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Tristar Holdings I LLC (the “Sponsor”), generating gross proceeds of $7,345,000, which is described in Note 4.
Transaction costs amounted to $25,995,754, consisting of $4,600,000 of underwriting fees, $10,350,000 of deferred underwriting fees, $12,546,764 for the fair value of the Founder Shares attributable to the anchor investors (see Note
6
), and $1,003,989 of offering costs, partially offset by the reimbursement of $2,505,000 of offering expenses by the underwriters. The Company’s remaining cash after payment of the offering costs is held outside of the Trust Account for working capital purposes.
Following the closing of the Initial Public Offering and over-allotment option, an amount of $232,300,000 from the net proceeds of the sale of the Units in the Initial Public Offering and over-allotment option and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and is invested only in U.S. government treasury obligations with maturities of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of the initial Business Combination; (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to redeem 100
% of the public shares if the Company does not complete the initial Business Combination within 18 months (or 21 months from the Closing of the Initial Public Offering if the Company has executed a letter of intent, agreement in principle or definitive agreement for its initial business combination within 18 months from the closing of the Initial Public Offering but has not completed its initial business combination within such 18 month period) from the closing of the Initial Public Offering; and (iii) absent an initial Business Combination within 18 months (or 21 months, as applicable) from the closing of the Initial Public Offering or with respect to any other material provisions relating to shareholders’ rights or
pre-initial
Business Combination activity, the return of the funds held in the trust account to the public shareholders as part of the redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted fund and may hinder the Company’s ability to complete a business combination. If the Company is unable to complete the initial Business Combination, the Company’s public shareholders may only receive their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and the warrants will expire worthless.
 
5
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note 1—Description of Organization and Business Operations and Liquidity—Continued
 
The Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount held in the Trust Account ($10.10 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480,
 Distinguishing Liabilities from Equity
 (“ASC 480”).
The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon consummation of such Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association as then in effect (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders, anchor investors, and management team have agreed to vote any Founder Shares held by them in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction.
Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.
The initial shareholders (as described in Note 5) have agreed to (i) waive their redemption rights with respect to any Founder Shares they hold in connection with the completion of an initial Business Combination, (ii) waive their redemption rights with respect to any Founder Shares and Public Shares they hold in connection with a shareholder vote to approve an amendment to the Amended and Restated Memorandum and Articles of Association to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within 18
months (or 21 months, as applicable) from the closing of the Initial Public Offering or with respect to any other material provisions relating to shareholders’ rights or
pre-initial
Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete an initial Business Combination w
ithin 18
months (or 21 months, as applicable) from the Initial Public Offering. However, if the initial shareholders or anchor investors acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period (as defined below).
 
6
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note 1—Description of Organization and Business Operations and Liquidity—Continued
 
The Company will have until 18 months (or 21 months, as applicable) from the closing of the Initial Public Offering (the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to
$100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note
7
) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.10 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.10 per Public Share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third-party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity
, Capital Resources
and Going Concern
As of June 30, 2022 and December 31, 2021, the Company had cash outside the Trust Account of $761,186 and $1,231,992 available for working capital needs respectively. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2022 and December 31, 2021, none of the amount in the Trust Account was available to be withdrawn as described above.
Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 5) for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.
 
7
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note 1—Description of Organization and Business Operations and Liquidity—Continued
 
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until April 13, 2023 to consummate a Business Combination, or July 13, 2023 if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination by April 13, 2023. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur and an extension is not requested by the Sponsor, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 13, 2023.
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.
Note 2—Restatement of Previously Issued Financial Statements
The Company determined that a listing fee totaling $103,359 incurred by the New York Stock Exchange which was recorded and included in the Form 10-Q for the period ended March 31, 2022 should have been recorded as an accrued liability as of December 31, 2021 due to the fact that the fee was related to 2021 even though the invoice was received in 2022. The Company also determined that the $85,000 New York Stock Exchange invoice received in the first quarter of 2022 is an annual fee for all of 2022 and should be recorded as a prepaid expense and amortized monthly.
In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality”, and SEC Staff Accounting Bulletin No. 108 “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements:’ the Company evaluated the changes and has determined that the related impact were material to the previously presented financial statements. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued financial statements should be restated. As such the Company is reporting these restatements for the period March 31, 2022 in this Quarterly Report.
Impact of the Restatement
The impact to the balance sheet, statement of operations, statement of changes in shareholders’ deficit and cash flows are presented below:
 
Balance Sheet
  
As Previously
Reported
 
 
Restatement
Adjustment
 
  
 
 
 
As Restated
 
Assets
  
      
 
      
  
      
 
      
Prepaid expenses
 - current portion
  
$
317,957
 
 
$
63,750
 
  
 
(1
) 
 
$
381,707
 
Total Assets
  
 
233,679,318
 
 
 
63,750
 
  
      
 
 
233,743,068
 
Total Liabilities
  
 
18,040,951
 
 
 
—  
 
  
      
 
 
18,040,951
 
Class A ordinary shares 23,000,000 shares, subject to possible redemption at $10.10 per share
  
 
232,300,000
 
 
 
—  
 
  
      
 
 
232,300,000
 
Shareholder’s equity
  
      
 
      
  
      
 
      
Preferred shared, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
  
 
—  
 
 
 
—  
 
  
      
 
 
-
 
Class A ordinary shares, $0.0001 par value; 90,000,000 shares authorized; 0.00 issued or outstanding (excluding 20,000,000 shares subject to possible redemption)
  
 
—  
 
 
 
—  
 
  
      
 
 
-
 
Class B ordinary shares, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding
  
 
575
 
 
 
—  
 
  
      
 
 
575
 
Additional paid-in-captial
  
 
—  
 
 
 
—  
 
  
      
 
 
-
 
Accumulates deficit
  
 
(16,662,208
) 
 
 
63,750
 
  
 
(1
) 
 
 
(16,598,458
) 
 
  
 
 
 
 
 
 
 
  
      
 
 
 
 
Total shareholder’s equity
  
 
(16,661,633
) 
 
 
63,750
 
  
      
 
 
(16,597,883
) 
 
  
 
 
 
 
 
 
 
  
      
 
 
 
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  
$
233,679,318
 
 
 
—  
 
  
      
 
$
233,743,068
 
 
  
 
 
 
 
 
 
 
  
      
 
 
 
 
(1) To reclass $85,000
2022 NYSE listing fee expense to prepaid, net of amortization for Q1
of
($
21,250
)
 
Statement of Operations
  
As Previously
Reported
 
 
Restatement
Adjustment
 
  
 
 
 
As Restated
 
General and administrative expenses
  
$
(424,846
) 
 
$
167,109
 
  
 
(1
) 
 
$
(257,737
) 
Total other income
  
 
2,152,254
 
 
 
—  
 
  
      
 
$
2,152,254
 
 
  
 
 
 
 
 
 
 
  
      
 
 
 
 
Net income
  
 
1,727,408
 
 
 
167,109
 
  
      
 
 
1,894,517
 
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to redemption
  
 
 23,000,000
 
 
 
 —
 
  
      
 
 
 23,000,000
 
Basic and diluted net income per share, outstanding, Class A ordinary shares subject to redemption
  
$
 0.06
 
 
$
 0.01
 
  
      
 
$
 0.07
 
Basic and diluted weighted average shares outstanding, Class B ordinary shares
  
 
 5,750,000
 
 
 
 —
 
  
      
 
 
 5,750,000
 
Basic and diluted net income per share, Class B ordinary shares
  
$
 0.06
 
 
$
 0.01
 
  
      
 
$
 0.07
 
 
(1)
To reduce NYSE listing fee expense totaling $188,359 ($103,359 recorded December 31, 2021 and $85,000
reclassed to prepaid expenses as of March 31, 2022 net amortization amount for Q1
of $21,250
)
 
Statement of Changes in Shareholder’s Deficit
  
As Previously
Reported
 
 
Restatement
Adjustment
 
 
 
 
 
As Restated
 
Balance—January 1, 2022—Accumulated deficit
  
$
(18,389,616
) 
 
$
(103,359
) 
 
 
(1
) 
 
$
(18,492,975
) 
Balance—January 1, 2022—Accumulated deficit
  
 
(18,389,041
) 
 
 
(103,359
) 
 
 
(1
) 
 
 
(18,492,400
) 
Net income
  
 
1,727,408
 
 
 
167,109
 
 
 
(3
) 
 
 
1,894,517
 
Total accumulated deficit—March 31, 2022
  
 
(16,662,208
) 
 
 
63,750
 
 
 
(2
) 
 
 
(16,598,458
) 
Total accumulated deficit—March 31, 2022
  
 
(16,661,633
) 
 
 
63,750
 
 
 
(2
) 
 
 
(16,597,883
) 
 
(1)
To record 2021 NYSE listing fee as of December 31, 2021 totaling $103,359
(2)
To reclass $85,000
2022 NYSE listing fee expense to prepaid, net of amortization amount for Q1
 of
($
21,250)
(3)
To reduce NYSE listing fee expense totaling $188,359 ($103,359 recorded December 31, 2021 and $85,000
reclassed to prepaid expenses as of March 31, 2022 net amortization amount for
Q1 of $21,250
)
 
Statement of Cash Flows
  
As Previously
Reported
 
 
Restatement
Adjustment
 
 
 
 
 
As Restated
 
Net income
  
$
1,727,408
 
 
$
167,109
 
 
 
(1
) 
 
$
1,894,517
 
Prepaid expenses
  
$
93,200
 
 
($
63,750
) 
 
 
(2
) 
 
$
29,450
 
Accounts Payable and accrued expenses
  
$
(3,106
) 
 
$
(103,359
) 
 
 
(3
) 
 
$
(106,465
) 
 
(1)
To reduce NYSE listing fee expense totaling $188,359 ($103,359 recorded December 31, 2021 and $85,000
reclassed to prepaid expenses as of March 31, 2022 net amortization amount for Q1 of
 $21,250
)
(2)
To reclass $85,000
2022 NYSE listing fee expense to prepaid, net of amortization amount for Q1 of
 
($
21,250)
(3)
To record 2021 NYSE listing fee as of December 31, 2021 totaling $103,359
Note 3—Significant Accounting Policies
Basis of Presentation
The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of June 30, 2022 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s Annual Report on
Form 10-K for
the year ended December 31, 2021. The financial information as of December 31, 2021 is derived from the audited financial statements presented in the Company’s Annual Report on
Form 10-K
for the year ended December 31, 2021. The interim results for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-
 
8
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
3
—Significant Accounting Policies—Continued
 
emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2022 and December 31, 2021.
Investments Held in Trust Account
As of June 30, 2022 and December 31, 2021, the assets held in Trust Account were held in money market funds which invest in U.S. Treasury securities.
The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. At June 30, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities.
 
The Company classifies its U.S. Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments - Debt and Equity Securities.” 
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
As of June 30, 2022 and December 31, 2021, 23,000,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.
 
9
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
3
—Significant Accounting Policies—Continued
 
Offering Costs associated with the Initial Public Offering
The Company complies with the requirements of ASC
340-10-S99-1
and SEC Staff Accounting Bulletin Topic 5A -
 Expenses of Offering
. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs directly attributable to the issuance of an equity contract to be classified in equity are recorded as a reduction in equity. Offering costs for equity contracts that are classified as assets and liabilities are expensed immediately. The Company incurred offering costs amounting to $25,995,754, consisting of $4,600,000 of underwriting fees, $10,350,000 of deferred underwriting fees, $12,546,764 for the fair value of the Founder Shares attributable to the anchor investors (see Note 5), and $1,003,989 of offering costs, partially offset by the reimbursement of $2,505,000 of offering expenses by the underwriters. Of the $25,995,754 in offering costs, $24,414,399 were charged to shareholders’ deficit, and $1,581,355 were expensed immediately.
Income Taxes
The Company accounts for income taxes under ASC 740,
 Income Taxes
 (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s condensed financial statements. Since the Company was incorporated on March 5, 2021, the evaluation was performed for the 2021 tax year which will be the only period subject to examination.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There are no taxes in the Cayman Islands and accordingly income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements.
Share-based Compensation
The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the sharebased payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.
 
10
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
3
—Significant Accounting Policies—Continued
 
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and
re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or
non-current
based on whether or not
net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date
.
Warrant Liabilities
The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”), in accordance with ASC
815-40,
“Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the statement of operations in the period of change.
Fair Value of Financial Instruments
ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value.
The carrying amounts reflected in the balance sheet for cash, prepaid expenses, due from related party, cash held in trust account, accounts payable, and accrued offering costs and expenses approximate fair value due to their short-term nature.
The three levels of the fair value hierarchy under ASC 820 are as follows:
Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.
Level 2—Pricing inputs are other than quoted prices included within Level 1 that are observable for the investment, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation.
 
11
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
3
—Significant Accounting Policies—Continued
 
In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.
See Note
10
for additional information on assets and liabilities measured at fair value.
Net Income (Loss) Per Ordinary Share
The Company applies the
two-class
method in calculating net loss per ordinary share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of ordinary share. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per ordinary share is computed by dividing the pro rata net loss between the Class A ordinary share and the Class B ordinary share by the weighted average number of ordinary shares outstanding. The calculation of diluted loss per ordinary share does not consider the effect of the warrants and rights issued in connection with the Public Offering since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 18,845,000 shares of Class A ordinary share in the aggregate.
 
    
Three

Months Ended

June 30, 2022
     
Three
Months Ended
June 30, 2021
  
Ordinary shares subject to possible redemption
                  
Numerator: Earnings allocable to Redeemable Class A ordinary shares
                  
Net income allocable to Class A ordinary shares subject to possible redemption
    $   4,191,010      $ —    
Denominator: Redeemable Class A ordinary shares,
                  
Basic and diluted weighted average shares outstanding
      23,000,00       
—  
  
    
 
 
     
 
 
  
Basic and diluted net income per share, Redeemable Class A ordinary share
    $ 0.18      $ —    
    
 
 
     
 
 
  
Non-redeemable
ordinary shares
                  
Numerator: Net income allocable to Class B ordinary shares not subject to redemption
                  
Net income (loss) allocable to Class B ordinary shares not subject to redemption
    $ 1,047,752      $ (109,762 ) 
Denominator: Weighted Average
non-redeemable
Class B ordinary shares
                  
Basic and diluted weighted average shares outstanding
      5,750,000        5,000,000  
    
 
 
     
 
 
  
Basic and diluted net income (loss) per share
    $ 0.18      $ (0.02
)
 
    
 
 
     
 
 
  
 
12
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
3
—Significant Accounting Policies—Continued
 
    
Six

Months Ended

June 30,

2022
     
For the
period from
March 5,
2021
(inception) to
June 30,
2021
  
Ordinary shares subject to possible redemption
                  
Numerator: Earnings allocable to Redeemable Class A ordinary shares
                  
Net income allocable to Class A ordinary shares subject to possible redemption
    $  5,706,623      $ —    
Denominator: Redeemable Class A ordinary shares,
                  
Basic and diluted weighted average shares outstanding
      23,000,00        —    
    
 
 
     
 
 
  
Basic and diluted net income per share, Redeemable Class A ordinary share
    $ 0.25      $ —    
    
 
 
     
 
 
  
Non-redeemable
ordinary shares
                  
Numerator: Net income allocable to Class B ordinary shares not subject to redemption
                  
Net income (loss) allocable to Class B ordinary shares not subject to redemption
    $ 1,426,656      $ (121,066 ) 
Denominator: Weighted Average
non-redeemable
Class B ordinary shares
                  
Basic and diluted weighted average shares outstanding
      5,750,000        5,000,000  
    
 
 
     
 
 
  
Basic and diluted net income (loss) per share
    $ 0.25      $ (0.02
)

    
 
 
     
 
 
  
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
 Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
 (“ASU
2020-06”)
to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU
2020-06
would have on its financial position, results of operations or cash flows
.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Note
4
—Initial Public Offering
Pursuant to the Initial Public Offering, the Company sold 20,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and
one-half
of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note
8
). The Company granted the underwriters an option, exercisable for 45 days from the date of the prospectus, October 13, 2021, to purchase up to 3,000,000 additional Units. The underwriters exercised the over-allotment option on November 3, 2021 by purchasing 3,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and
one-half
of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note
8
).
 
13
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
 
Note
5
—Private Placement
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,775,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($6,775,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. On November 3, 2021, pursuant to the underwriters exercising the additional Units (see Note
4
), the Sponsor purchased an additional 570,000 Private Placement Warrants at a price of $1.00.
Note 6 —Related Party Transactions
Founder Shares
On March 15, 2021, the Sponsor subscribed to purchase 7,187,500 Class B ordinary shares of the Company, par value $0.0001 per share (the “Founder Shares”), and fully paid for those shares on March 19, 2021. In August 2021, the Sponsor forfeited 1,437,500 Founder Shares, resulting in a decrease in the total number of Founder Shares from 7,187,500 to 5,750,000. All shares and associated amounts have been retroactively restated to reflect the share forfeiture.
The initial shareholders have agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, or sold until the earlier of (i) 
one
year
after the completion of a Business Combination or (ii) subsequent to an initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after an initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other
property.
In March 2021, the Sponsor transferred 50,000 Founder Shares (25,000 shares each) to the chief financial officer and chief operating officer at their original purchase price. In November 2021, the Sponsor transferred a total of 150,000 Founder Shares to six director nominees (25,000 shares to each director nominee) for no consideration. The Company estimated the fair value of the Founder Shares attributable to the director nominees to be $1,116,000 or $7.44 per share. The transfer of Founder Shares is in the scope of FASB ASC Topic 718 “Compensation Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and expensed when earned. Shares granted to the directors, chief financial officer and chief operating officer are forfeited if their status as director or officer is terminated for any reason prior to the date of the initial Business Combination, and as such, there has been no stock-based compensation expense recognized in the accompanying financial statements.
A total of eleven anchor investors each purchased an allocation of units as determined by the underwriters, in the Initial Public Offering at the offering price of $10.00 per unit. Pursuant to such units, the anchor investors have not been granted any shareholder or other rights in addition to those afforded to the Company’s other public shareholders. Further, the anchor investors are not required to (i) hold any units, Class A ordinary shares or warrants they may purchase in the Initial Public Offering or thereafter for any amount of time, (ii) vote any Class A ordinary shares they may own at the applicable time in favor of the Business Combination or (iii) refrain from exercising their right to redeem their public shares at the time of the Business Combination. The anchor investors will have the same rights to the funds held in the trust account with respect to the Class A ordinary shares underlying the units purchased in the Initial Public Offering as the rights afforded to the Company’s other public shareholders.
Each anchor investor has entered into separate investment agreements with the Company and the Sponsor pursuant to which each anchor investor agreed to purchase a specified number of Founder Shares. One anchor investor purchased 333,333 Founder Shares at a purchase price of $3 per share. In addition, the Sponsor sold to the other ten anchor investors an aggregate of 1,585,000 of Founder Shares at a purchase price of $0.01 per share. Pursuant to the investment agreements, the anchor investors have agreed to (a) vote any Founder Shares held by them in favor of the Business Combination and (b) subject any Founder Shares held by them to the same
lock-up
restrictions as the Founder Shares held by the Sponsor.
The Company estimated the fair value of the Founder Shares attributable to the anchor investors to be $13,562,614 or $7.07 per share. The excess of the fair value of the Founder Shares sold over the purchase price of $1,015,850 was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost will be allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities will be expensed immediately in the statement of operations. Offering costs allocated to the Public Shares will be charged to shareholders’ deficit upon the completion of the Initial Public Offering.
 
14
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
6
—Related Party Transactions—Continued
 
Promissory Note—Related Party
On March 9, 2021, the Sponsor agreed to loan the Company an aggregate of up to $100,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was amended in April, 2021 and then again in May, 2021, to increase the aggregate principal balance ultimately up to $300,000. This loan was
non-interest
bearing and payable on the earlier of (i) September 30, 2021 or (ii) the consummation of the Initial Public Offering. The outstanding balance under the Promissory Note was repaid on October 18, 2021 upon the closing of the Initial Public Offering.
Administrative Support Agreement
The Company has entered into an agreement with the Sponsor, to pay a total of $10,000 per month for office space, secretarial and administrative services. Upon the completion of an initial Business Combination or liquidation, the Company will cease paying these monthly fees. As of June 30, 2022 and December 31, 2021 the Company owes the Sponsor $84,516
and 
$24,516
,
 
respectively, and is included in accrued expenses on the accompanying condensed balance sheets.
Related Party Loans
In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
Note
7
—Commitments and Contingencies
Registration and Shareholder Rights Agreement
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination. The Company bears the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company paid an underwriting discount of $0.20 per Public Unit Offering price to the underwriters at the closing of the Initial Public Offering and over-allotment option. The underwriting discount was paid in cash. In addition, the Company has agreed to pay deferred underwriting commissions of $0.45 per Public Unit, or $10,350,000 in the aggregate. The deferred underwriting commission will become payable to the underwriters from the amount held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, including the performance of services specified therein.
 
15
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
7
—Commitments and Contingencies—Continued
 
Forward Purchase Agreements
On June 21, 2021 and July 26, 2021, respectively, the Company entered into forward purchase agreements pursuant to which one anchor investor and one institutional accredited investor that are not affiliated with the Sponsor or any member of the Company’s management, have subscribed to purchase from the Company an aggregate of 4,500,000 Class A ordinary shares at a price of $10.00 per share as described in the forward purchase agreements, each in a private placement that will close immediately prior to the closing of our initial Business Combination. The terms of the forward purchase shares will generally be identical to the Class A ordinary shares included in the Units being sold in this offering, except that they will have registration rights and rights of first refusal with respect to any business combination financing, as described in the forward purchase agreements. One of the forward purchase investors may elect, in its sole discretion, to purchase convertible debt securities
or non-convertible debt
instruments in lieu of the forward purchase shares, or a combination thereof, for an aggregate purchase price of up to $25,000,000.
Note
8
—Warrant Liability
Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided, that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The warrants will have an exercise price of $11.50 per share. If (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor, initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price.
 
16
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
8
—Warrant Liability—Continued
 
The Private Placement Warrants will be identical to the Public Warrants, except that (1) the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants will
be non-redeemable (except
as described below) so long as they are held by the Sponsor or its permitted transferees, (3) the Private Placement Warrants may be exercised by the holders on a cashless basis and (4) the holders of the Private Placement Warrants (including with respect to the ordinary shares issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants.
The Company may call the Public Warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption; and
 
  •  
if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted
for split-up of
ordinary shares, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
the 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.
In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
The Company accounts for the 18,845,000 warrants issued in connection with the Initial Public Offering (including 11,500,000 Public Warrants and 7,345,000 Private Placement Warrants) in accordance with the guidance contained in ASC
815-40.
Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability.
The accounting treatment of derivative financial instruments requires that the Company record the warrants as derivative liabilities at fair value upon the closing of the Initial Public Offering. The Public Warrants have been allocated a portion of the proceeds from the issuance of the Units equal to its fair value. These warrant liabilities are subject to
re-measurement
at each balance sheet date. With each such
re-measurement,
the warrant liability will be adjusted to its current fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.
Note
9
—Shareholders’ Deficit
Class
 A Ordinary Shares
—The Company is authorized to issue 90,000,000 Class A ordinary shares with a par value of $0.0001 per share. At June 30, 2022, there were no Class A ordinary shares issued and outstanding, excluding 23,000,000 Class A ordinary shares subject to possible redemption.
Class
 B Ordinary Shares
—The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. At June 30, 2022, there were 5,750,000 Class B ordinary shares issued and outstanding.
Shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders; provided that, prior to the completion of the initial Business Combination, holders of the Class B ordinary shares will have the right to elect all of the Company’s directors and remove members of the Company’s board of directors for any reason. Holders of the Public Shares will not be entitled to vote on the Company’s election of directors during
 
17
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
9
— Shareholders’ Deficit—Continued
 
such time. In addition, prior to the completion of the initial Business Combination, holders of a majority of the outstanding Class B ordinary shares may remove a member of the Company’s board of directors for any reason. These provisions of the Company’s memorandum and articles of association governing the appointment or removal of directors prior to the initial Business Combination may only be amended by a special resolution passed by no less
than two-thirds of
the Company’s ordinary shares who attend and vote at the Company’s general meeting which shall include the affirmative vote of a simple majority of the Company’s Class B ordinary shares. With respect to any other matter submitted to a vote of the Company’s shareholders, including any vote in connection with the initial Business Combination, holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holders, on
a one-for-one basis.
In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, including pursuant to a specified future issuance, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the then-outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on
an as-converted basis,
20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Proposed Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued or issuable to any seller in the initial Business Combination).
Preferred Shares
 —The Company is authorized to issue 1,000,000 shares of preferred shares, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2022, there were no preferred shares issued or outstanding.
Dividends
The Company has not paid any cash dividends on the ordinary shares to date and does not intend to pay cash dividends prior to the completion of the initial Business Combination.
Note
10
—Fair Value Measurements
The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value:
 
 
  
As of June 30, 2022
 
 
  
Level 1
 
  
Level 2
 
  
Level 3
 
  
Total
 
Assets:
                                    
Marketable securities held in Trust Account
   
$

 232,461,777      $ —        $ —        $  232,461,777  
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
$
232,461,777
     
$
—  
 
   
$
—  
 
   
$
232,461,777
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
 
  
As of December 31, 2021
 
 
  
Level 1
 
  
Level 2
 
  
Level 3
 
  
Total
 
Assets:
                                    
Marketable securities held in Trust Account
   
$

 232,302,491      $ —        $ —        $  232,302,491  
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
$
232,302,491
     
$
—  
 
   
$
—  
 
   
$
232,302,491
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
18
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note
10
—Fair Value Measurements—Continued
 
                                                                                                             
    
As of June 30, 2022
  
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Liabilities:
                                    
Warrant liability – Public Warrants
   
$
1,380,000
     
$
—  
     
$
—  
     
$
 1,380,000
 
Warrant liability—Private Placement Warrants
   
 
—  
 
   
 
—  
 
   
 
881,400
 
   
 
881,400
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
$
1,380,000
     
$
—  
     
$
881,400
 
   
$
2,261,400
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
                                                                                                             
    
As of December 31, 2021
  
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Liabilities:
                                    
Warrant liability – Public Warrants
   
$
5,865,000
     
$
—  
     
$
—  
     
$
 5,865,000
 
Warrant liability—Private Placement Warrants
   
 
—  
 
   
 
—  
 
   
 
3,819,400
 
   
 
3,819,400
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
$
5,865,000
     
$
—  
     
$
3,819,400
 
   
$
9,684,400
 
    
 
 
     
 
 
     
 
 
     
 
 
  
As of June 30, 2022 and December 31, 2021, the estimated fair value of the Public Warrants was determined by their public trading price and the estimated fair value of the Private Placement Warrants was determined using a probability-adjusted Black-Scholes method to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the Private Placement Warrants are determined using Level 3 inputs. Inherent in pricing models are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
The following table provides the significant inputs to the probability-adjusted Black-Scholes method for the fair value of the Private Warrants:
 
    
June 30, 2022
    
December 31, 2021
  
Stock price
    $ 9.85     $ 9.76  
Exercise price
    $ 11.50     $ 11.50  
Dividend yield
      —   %      —   % 
Expected term (in years)
      5       5  
Volatility
      2.3 %      12 % 
Risk-free rate
      3.01 %      1.26 % 
Fair value
    $ 0.12     $ 0.52  
The following tables provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
 
    
Private Placement
     
Public
     
Warrant Liabilities
  
Fair value at December 31, 2021
    $ 3,819,400      $ —        $ 3,819,400  
Change in fair value of Private Warrants
      (2,938,000 )                (2,938,000 ) 
    
 
 
     
 
 
     
 
 
  
Fair value at June 30, 2022
    $ 881,400      $ —        $ 881,400  
    
 
 
     
 
 
     
 
 
  
Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
 
19
TRISTAR ACQUISITION I CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
 
Note 1
1
—Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.
 
 
20
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “Company,” “Tristar” “our,” “us” or “we” refer to Tristar Acquisition I Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated on March 5, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase or similar business combination with one or more businesses or entities. We have not yet selected any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering (as defined below) and the private placement of the Private Placement Warrants, the proceeds of the sale of our shares in connection with our initial business combination (pursuant to forward purchase agreements or backstop agreements we may enter into), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing or other sources.
The issuance of additional shares in a business combination:
 
  •  
may significantly dilute the equity interest of investors;
 
  •  
may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares;
 
  •  
could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
 
  •  
may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us;
 
  •  
may adversely affect prevailing market prices for our Units, Class A ordinary shares and/or warrants; and
 
  •  
may not result in adjustment to the exercise price of our warrants. Similarly, if we issue debt or otherwise incur significant debt, it could result in:
 
  •  
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
 
  •  
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
 
  •  
our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;
 
  •  
our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;
 
  •  
our inability to pay dividends on our Class A ordinary shares;
 
  •  
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
 
  •  
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
 
21
  •  
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.
As indicated in the accompanying condensed financial statements, as of June 30, 2022, we had $761,186 of cash, and no deferred offering costs. Further, we expect to incur significant costs in the pursuit of our initial business combination. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.
Results of Operations and Known Trends or Future Events
Our only activities since inception have been organizational activities, those necessary to prepare for our Initial Public Offering, which was consummated on October 18, 2021 (the “Initial Public Offering”), and since the Initial Public Offering, searching for a prospective initial business combination. We will not generate any operating revenues until after completion of our initial business combination. We will
generate non-operating
income in the form of interest income on cash and cash equivalents. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements.
Liquidity, Capital Resources and Going Concern
Our liquidity needs have been satisfied through (i) $25,000 paid by our Sponsor to cover certain of our offering costs in exchange for the issuance of the Founder Shares to our Sponsor, (ii) the receipt of loans to us of $300,000 by our Sponsor under an unsecured promissory note, (iii) the net proceeds from the consummation of our Initial Public Offering and the sale of the Private Placement Warrants, and (iv) $1,015,850 paid by certain anchor investors in exchange for Founder Shares. The net proceeds from (i) the sale of the Units in the Initial Public Offering, after deducting
estimated non-reimbursed
offering expenses of $1,003,989, underwriting commissions of $4,600,000 (excluding deferred underwriting commissions of $10,350,000), and (ii) the sale of the Private Placement Warrants for a purchase price of $7,345,000 was $234,126,011. Of this amount, $232,300,000, plus interest earned on the trust account of $159,286, was placed in the trust account, which includes the deferred underwriting commissions described above. The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7
under the Investment Company Act which invest only in direct U.S. government treasury obligations. The remaining $1,741,011 was not held in the trust account.
We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less taxes payable and deferred underwriting commissions), to complete our initial business combination. We may withdraw interest income (if any) to pay income taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the trust account. We expect the interest income earned on the amount in the trust account (if any) will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
Prior to the completion of our initial business combination, we have available to us the $761,186 of proceeds held outside the trust account, as well as potential funds from loans from our Sponsor, its affiliates or members of our management team. We will use these funds to primarily identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business prior to our initial business combination, other than funds available from loans from our Sponsor, its affiliates or members of our management team. However, if our estimates of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our Sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
 
22
We expect our primary liquidity requirements during that period to include approximately $582,400 for directors and officers insurance premiums, $700,000 for legal, accounting, due diligence, travel and other expenses associated with structuring, negotiating and documenting successful business combinations; $200,000 for legal and accounting fees related to regulatory reporting obligations; $10,000 per month (or up to $180,000 in total) for office space and administrative and support services; $85,000 for the NYSE continued listing fees; and $425,000 for general working capital that will be used for miscellaneous expenses and reserves.
These amounts are estimates and may differ materially from our actual expenses. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund
a “no-shop”
provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund
a “no-shop”
provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until April 13, 2023 to consummate a Business Combination, or July 13, 2023 if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination by April 13, 2023. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur and an extension is not requested by the Sponsor, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 13, 2023.
Moreover, we may need to obtain additional financing to complete our initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in our trust account, or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.
Contractual Obligations
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination. The Company bears the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company paid an underwriting discount of $0.20 per Public Unit Offering price to the underwriters at the closing of the Initial Public Offering and over-allotment option. The underwriting discount was paid in cash. In addition, the Company has agreed to pay deferred underwriting commissions of $0.45 per Public Unit, or $10,350,000 in the aggregate. The deferred underwriting commission will become payable to the underwriters from the amount held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, including the performance of services specified therein.
Forward Purchase Agreement
On June 21, 2021 and July 26, 2021, respectively, the Company entered into forward purchase agreements pursuant to which one anchor investor and one institutional accredited investor that are not affiliated with the Sponsor or any member of the Company’s management, have subscribed to purchase from the Company an aggregate of 4,500,000 Class A ordinary shares at a price of $10.00 per share as described in the forward purchase agreements, each in a private placement that will close immediately prior to the closing
 
23
of our initial Business Combination. The terms of the forward purchase shares will generally be identical to the Class A ordinary shares included in the Units sold in the Initial Public Offering, except that they will have registration rights and rights of first refusal with respect to any business combination financing, as described in the forward purchase agreements. One of the forward purchase investors may elect, in its sole discretion, to purchase convertible debt securities or
non-convertible
debt instruments in lieu of the forward purchase shares, or a combination thereof, for an aggregate purchase price of up to $25,000,000.
Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Derivative instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and
re-valued
at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or
non-current
based on whether or not
net-cash
settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liabilities
The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”), in accordance with ASC
815-40,
“Derivatives and Hedging-Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the statement of operations in the period of change.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of ASC
340-10-S99-1
and SEC Staff Accounting Bulletin Topic 5A-
Expenses of Offering
. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs directly attributable to the issuance of an equity contract to be classified in equity are recorded as a reduction in equity. Offering costs for equity contracts that are classified as assets and liabilities are expensed immediately. The Company incurred offering costs amounting to $25,995,754, consisting of $4,600,000 of underwriting fees, $10,350,000 of deferred underwriting fees, $12,546,764 for the fair value of the Founder Shares attributable to the anchor investors (see Note 6), and $1,003,989 of offering costs, partially offset by the reimbursement of $2,505,000 of offering expenses by the underwriters. Of the $25,995,754 in offering costs, $24,414,399 were charged to shareholders’ deficit, and $1,581,355 were expensed immediately.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
 
24
Net Income (loss) per Ordinary Shares
The Company applies the
two-class
method in calculating net loss per ordinary share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of ordinary share. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net loss per ordinary share is computed by dividing the pro rata net loss between the Class A ordinary share and the Class B ordinary share by the weighted average number of ordinary shares outstanding. The calculation of diluted loss per ordinary share does not consider the effect of the warrants and rights issued in connection with the Public Offering since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 18,845,000 Class A ordinary shares in the aggregate.
Recent Issued Accounting Standards
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-06,
Debt—Debt with Conversion and Other Options (
Subtopic
470-20
) and Derivatives and Hedging—Contracts in Entity’s Own Equity (
Subtopic
815-40
): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
(“ASU
2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company is currently assessing the impact, if any, that ASU
2020-06
would have on its financial position, results of operations or cash flows.
Our management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.
Off-Balance
Sheet Arrangements
As of June 30, 2022, we did not have any
off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K
and did not have any commitments or contractual obligations. No unaudited quarterly operating data is included in this Annual Report as we have not conducted any operations to date.
JOBS Act
The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the principal executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule
12b-2
of the Exchange Act and are not required to provide the information otherwise required under this item. As of June 30, 2022, we were not subject to any market or interest rate risk. The net proceeds of the Initial Public Offering, including amounts in the Trust Account, will be invested in U.S. government securities with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule
2a-7
under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
 
25
We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.
Item 4. Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that our disclosure controls and procedures were not effective as of December 31, 2021, due solely to the material weaknesses in our internal control over financial reporting related the unrecorded liability totaling $103,359 from the New York Stock Exchange for the annual listing fee. As a result, we performed additional analyses as deemed necessary to ensure that our financial statements were prepared in accordance with accounting principles generally accepted in the United States of America. Accordingly, management believes that the financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
 
26
Changes in Internal Control over Financial Reporting
Except as set forth below, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter of 2022 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
While we have processes to identify and appropriately apply applicable accounting requirements, in light of the material weakness identified and the resulting restatements, our principal executive officer and principal financial and accounting officer performed additional accounting and financial analyses to ensure all accruals have been captured in the financial statements. Management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. We have enhanced and plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult. As we continue to evaluate and improve our financial reporting process, we may take additional actions to modify certain of these remediation measures. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to remediate the material weaknesses we have identified or avoid potential future material weaknesses.
 
27
PART II.—OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
As of the date of this Quarterly Report on Form
10-Q,
there have been no material changes to the risk factors disclosed in our Form
10-K
filed with the SEC on March 31, 2021, except for the below risk factors. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the
per-share
redemption amount received by public shareholders may be less than $10.10 per share.
The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule
2a-7
under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our amended and restated memorandum and articles of association, our public shareholders are entitled to receive their
pro-rata
share of the proceeds held in the trust account, plus any interest income, net of income taxes paid or payable (less, in the case we are unable to complete our initial business combination, $100,000 of interest to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the
per-share
redemption amount received by public shareholders may be less than $10.10 per share.
There is substantial doubt about our ability to continue as a “going concern.”
As of June 30, 2022 and December 31, 2021, we had cash outside the Trust Account of $761,186 and $1,231,992 available for working capital needs, respectively. We have incurred, and expect to continue to incur, significant costs in pursuit of an initial Business Combination. Our plans to raise capital and to consummate our initial Business Combination may not be successful. The initial deadline for us to complete our initial business combination is April 13, 2023, or July 13, 2023 if we have executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination by April 13, 2023. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements contained elsewhere in this report do not include any adjustments that might result from our inability to continue as a going concern through April 13, 2023, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date, or July 13, 2023, the scheduled liquidation date of the Company if it has executed a letter of intent, agreement in principle or definitive agreement for an Initial Business Combination by April 13, 2023, but has not completed a Business Combination.
Certain of our warrants are accounted for as a warrant liability and will be recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our ordinary shares or may make it more difficult for us to consummate an initial business combination.
Our Sponsor holds 7,345,000 Private Placement Warrants. We expect to account for these as a warrant liability and will record at fair value upon issuance any changes in fair value each period reported in earnings as determined by the company based upon a valuation report obtained from its independent third party valuation firm. The impact of changes in fair value on earnings may have an adverse effect on the market price of our ordinary shares. In addition, potential targets may seek a SPAC that does not have warrants that are accounted for as a warrant liability, which may make it more difficult for us to consummate an initial business combination with a target business.
Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.
We are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of operations.
 
28
On March 30, 2022, the U.S. Securities and Exchange Commission (the “SEC”) issued proposed rules relating to, among other items, increasing disclosures in business combination transactions involving special purpose acquisition companies (SPACs) and private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; changing the treatment of financial projections in SEC filings in connection with proposed business combination transactions; increasing the potential liability of certain participants in proposed business combination transactions; and a proposed safe harbor for SPACs under the Investment Company Act (including certain time limits to announce and consummate a business combination). These proposed rules, if adopted, whether in the form proposed or in revised form, may materially impact our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
In March 2021, our Sponsor paid $25,000, or approximately $0.0035 per share, to cover certain offering costs on our behalf in consideration of 7,187,500 Class B ordinary shares, par value $0.0001. Also in March 2021, our Sponsor transferred 50,000 of such shares (25,000 shares each) to Timothy Dawson, our Chief Financial Officer, and
Cathy-Ann
Martine-Dolecki, our Chief Operating Officer, in each case, at their original purchase price. In August 2021, the initial shareholders forfeited 1,437,500 of such Class B ordinary shares in the aggregate for no consideration. In November 2021, our Sponsor transferred 150,000 of such Founder Shares (25,000 shares each) to David Barksdale, Greg Boyd, David Jones, Alex Parker, Steven Rogers, and Robert Willis, each a director of the Company, in each case for their par value.
Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The total number of Class B ordinary shares outstanding equal 20.0% of the total number of Class A ordinary shares and Class B ordinary shares outstanding. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination, or earlier at the option of the holder thereof as described in the prospectus.
Our Sponsor has purchased an aggregate of 7,345,000 Private Placement Warrants, each exercisable to purchase one ordinary share at $11.50 per share, subject to adjustment, at a price of $1.00 per warrant $7,345,000 in the aggregate), in a private placement that closed simultaneously with the closing of the Initial Public Offering. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
No underwriting discounts or commissions were paid with respect to such sales.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
 
Exhibit

Number
   
Description
31.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document
101.SCH    XBRL Taxonomy Extension Schema Document
 
29
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    XBRL Taxonomy Extension Label Linkbase Document
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
 
*
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
30
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: August 19, 2022     TRISTAR ACQUISITION I CORP.
    By:  
/s/ William M. Mounger II
    Name:   William M. Mounger II
    Title:   Chief Executive Officer and Chairman of the Board
 
31
Tristar Acquisition I (NYSE:TRIS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Tristar Acquisition I.
Tristar Acquisition I (NYSE:TRIS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Tristar Acquisition I.